论文部分内容阅读
米非司酮(Mifepristone)配伍米索前列醇(Misoprostol,本文简称米索)终止中期妊娠已有成功的报道。但已往报道中米非司酮的用量一般≥200mg,药物费用较高。此外,对16周以上的中期妊娠采用国内较常用的利凡诺羊膜腔内注射法便可获得较高的引产成功率,而对小于16周的妊娠引产成功率较低。我们于1994年3月至1996年2月对不同剂量米非司酮配伍米索终止12～16周妊娠的效果进行了前瞻性的研究,以寻找出米非司酮较小的
Mifepristone (Mifepristone) and misoprostol (misoprostol, referred to as misoprostol) termination of midterm pregnancy has been reported. But it has been reported that the amount of mifepristone in general ≥ 200mg, higher drug costs. In addition, more than 16 weeks of medium-term pregnancy with the more commonly used domestic rivanol amniotic cavity injection can be a higher success rate of induction of labor, while less than 16 weeks of pregnancy induced labor success rate is low. We conducted a prospective study from March 1994 to February 1996 on the effect of different doses of mifepristone combined with misoprost on pregnancies of 12 to 16 weeks in order to find out that mifepristone is smaller